Industry Growth Insights published a new data on “Mental Disorder Treatment Market”. The research report is titled “Mental Disorder Treatment Market research by Types (Medications, Self-help Therapies), By Applications (Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, Others), By Players/Companies Allergan Plc, Eli Lilly and Company, VistaGen Therapeutics, Sanofi S.A, Novartis International AG, Mylan N.V, Amneal Pharmaceuticals LLC, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Limited, Lupin Limited, Janssen Pharmaceutica, Bristol Myers Squibb, Sumitomo Dainippon Pharma Co., Ltd”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mental Disorder Treatment Market Research Report
By Type
Medications, Self-help Therapies
By Application
Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, Others
By Companies
Allergan Plc, Eli Lilly and Company, VistaGen Therapeutics, Sanofi S.A, Novartis International AG, Mylan N.V, Amneal Pharmaceuticals LLC, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Limited, Lupin Limited, Janssen Pharmaceutica, Bristol Myers Squibb, Sumitomo Dainippon Pharma Co., Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Mental Disorder Treatment Market Report Segments:
The global Mental Disorder Treatment market is segmented on the basis of:
Types
Medications, Self-help Therapies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan Plc
- Eli Lilly and Company
- VistaGen Therapeutics
- Sanofi S.A
- Novartis International AG
- Mylan N.V
- Amneal Pharmaceuticals LLC
- Cipla Ltd
- Sun Pharmaceutical Industries Ltd
- Glenmark Pharmaceuticals Limited
- Lupin Limited
- Janssen Pharmaceutica
- Bristol Myers Squibb
- Sumitomo Dainippon Pharma Co., Ltd
Highlights of The Mental Disorder Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medications
- Self-help Therapies
- By Application:
- Depression
- Bipolar Disorder
- Schizophrenia
- Dementia
- Post-traumatic Stress Disorder
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mental Disorder Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mental disorder treatment is a combination of therapies that aim to help people with mental disorders live more productive and fulfilling lives. Treatment may include medication, therapy, support groups, and other interventions.
Some of the major companies in the mental disorder treatment market are Allergan Plc, Eli Lilly and Company, VistaGen Therapeutics, Sanofi S.A, Novartis International AG, Mylan N.V, Amneal Pharmaceuticals LLC, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Limited, Lupin Limited, Janssen Pharmaceutica, Bristol Myers Squibb, Sumitomo Dainippon Pharma Co., Ltd.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mental Disorder Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mental Disorder Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mental Disorder Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mental Disorder Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mental Disorder Treatment Market Size & Forecast, 2018-2028
4.5.1 Mental Disorder Treatment Market Size and Y-o-Y Growth
4.5.2 Mental Disorder Treatment Market Absolute $ Opportunity
Chapter 5 Global Mental Disorder Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mental Disorder Treatment Market Size Forecast by Type
5.2.1 Medications
5.2.2 Self-help Therapies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mental Disorder Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mental Disorder Treatment Market Size Forecast by Applications
6.2.1 Depression
6.2.2 Bipolar Disorder
6.2.3 Schizophrenia
6.2.4 Dementia
6.2.5 Post-traumatic Stress Disorder
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mental Disorder Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mental Disorder Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mental Disorder Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Mental Disorder Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mental Disorder Treatment Market Size Forecast by Type
9.6.1 Medications
9.6.2 Self-help Therapies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mental Disorder Treatment Market Size Forecast by Applications
9.10.1 Depression
9.10.2 Bipolar Disorder
9.10.3 Schizophrenia
9.10.4 Dementia
9.10.5 Post-traumatic Stress Disorder
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mental Disorder Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Mental Disorder Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mental Disorder Treatment Market Size Forecast by Type
10.6.1 Medications
10.6.2 Self-help Therapies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mental Disorder Treatment Market Size Forecast by Applications
10.10.1 Depression
10.10.2 Bipolar Disorder
10.10.3 Schizophrenia
10.10.4 Dementia
10.10.5 Post-traumatic Stress Disorder
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mental Disorder Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mental Disorder Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mental Disorder Treatment Market Size Forecast by Type
11.6.1 Medications
11.6.2 Self-help Therapies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mental Disorder Treatment Market Size Forecast by Applications
11.10.1 Depression
11.10.2 Bipolar Disorder
11.10.3 Schizophrenia
11.10.4 Dementia
11.10.5 Post-traumatic Stress Disorder
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mental Disorder Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Mental Disorder Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mental Disorder Treatment Market Size Forecast by Type
12.6.1 Medications
12.6.2 Self-help Therapies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mental Disorder Treatment Market Size Forecast by Applications
12.10.1 Depression
12.10.2 Bipolar Disorder
12.10.3 Schizophrenia
12.10.4 Dementia
12.10.5 Post-traumatic Stress Disorder
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mental Disorder Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mental Disorder Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mental Disorder Treatment Market Size Forecast by Type
13.6.1 Medications
13.6.2 Self-help Therapies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mental Disorder Treatment Market Size Forecast by Applications
13.10.1 Depression
13.10.2 Bipolar Disorder
13.10.3 Schizophrenia
13.10.4 Dementia
13.10.5 Post-traumatic Stress Disorder
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mental Disorder Treatment Market: Competitive Dashboard
14.2 Global Mental Disorder Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan Plc
14.3.2 Eli Lilly and Company
14.3.3 VistaGen Therapeutics
14.3.4 Sanofi S.A
14.3.5 Novartis International AG
14.3.6 Mylan N.V
14.3.7 Amneal Pharmaceuticals LLC
14.3.8 Cipla Ltd
14.3.9 Sun Pharmaceutical Industries Ltd
14.3.10 Glenmark Pharmaceuticals Limited
14.3.11 Lupin Limited
14.3.12 Janssen Pharmaceutica
14.3.13 Bristol Myers Squibb
14.3.14 Sumitomo Dainippon Pharma Co., Ltd
